ELPEN Pharmaceutical Co. Inc. S.A. Krka d.d., Novo mesto TAD Pharma GmbH
PolandAll drugs from this manufacturer
-
The medicine is used to increase the number of platelets in the blood. It is intended for the treatment of immune thrombocytopenia in individuals over 1 year of age (after previous treatment with other methods) and in adults with hepatitis C virus infection who have a low platelet count.
Dosage form: tablets, film-coated
Active substance Dosage eltrombopag 25 mg ATC: B02BX05
-
The medicine is used to increase the number of blood platelets. It is intended for the treatment of immune thrombocytopenia in individuals over 1 year of age (after failure of other methods) and in adults with a low platelet count caused by hepatitis C virus infection.
Dosage form: tablets, film-coated
Active substance Dosage eltrombopag 50 mg ATC: B02BX05
-
The medicine is used to increase the number of blood platelets. It is intended for the treatment of immune thrombocytopenia in individuals over 1 year of age (after failure of other methods) and in adults with hepatitis C who have experienced a low platelet count during interferon treatment.
Dosage form: tablets, film-coated
Active substance Dosage eltrombopag 75 mg ATC: B02BX05